Publicaciones (307) Publicaciones en las que ha participado algún/a investigador/a

2024

  1. Biodegradable polydioxanone stents: histologic and structural effects in an experimental model of tracheal stenosis

    European Journal of Cardio-thoracic Surgery , Vol. 65, Núm. 4

  2. Does remission in systemic lupus erythematosus according to the 2021 DORIS definition match the treating rheumatologist's judgement?

    Rheumatology (Oxford, England), Vol. 63, Núm. 1, pp. 72-78

  3. Lack of awareness of systemic lupus erythematosus and its consequences in a cohort of moderate and severe patients in Spain: The LupusVoice study

    Lupus, Vol. 33, Núm. 7, pp. 663-674

  4. Multidisciplinary consensus on the use of hydroxychloroquine in patients with systemic lupus erythematosus

    Reumatologia Clinica, Vol. 20, Núm. 6, pp. 312-319

  5. Vasoactive intestinal peptide exerts an osteoinductive effect in human mesenchymal stem cells

    BioFactors

2023

  1. Central nervous system involvement in systemic lupus erythematosus: Data from the Spanish Society of Rheumatology Lupus Register (RELESSER)

    Seminars in Arthritis and Rheumatism, Vol. 58

  2. Development of a Ready-to-Eat Fish Product Enriched with Fish Oil Entrapped in a κ-Carrageenan Egg White Fish Protein Hydrolysate Dry Powder

    Foods, Vol. 12, Núm. 11

  3. Disease control in patients with ankylosing spondylitis in real clinical practice in Spain: Results of the MIDAS study

    Reumatologia Clinica, Vol. 19, Núm. 2, pp. 99-105

  4. Disease control in patients with psoriatic arthritis in real clinical practice in Spain: MiDAS study

    Reumatologia Clinica, Vol. 19, Núm. 4, pp. 204-210

  5. Expert Consensus: Main Risk Factors for Poor Prognosis in COVID-19 and the Implications for Targeted Measures against SARS-CoV-2

    Viruses, Vol. 15, Núm. 7

  6. Gender biases in Spanish rheumatology: Perception and facts

    Reumatologia Clinica, Vol. 19, Núm. 7, pp. 392-401

  7. Influenza Adverse Events in Patients with Rheumatoid Arthritis, Ulcerative Colitis, or Psoriatic Arthritis in the Tofacitinib Clinical Development Programs

    Rheumatology and Therapy, Vol. 10, Núm. 2, pp. 357-373

  8. Neurocientíficas en la Escuela de Cajal: ellas también son Escuela. Fisiología

    Fisiología (Santa Cruz de Tenerife. Ed. impresa), Vol. 25, Núm. 1, pp. 4-9

  9. Occurrence of SARS-CoV-2 viremia is associated with genetic variants of genes related to COVID-19 pathogenesis

    Frontiers in Medicine, Vol. 10

  10. Pregnancy outcomes in 1869 pregnancies in a large cohort from the Spanish Society of Rheumatology Lupus Register (RELESSER)

    Seminars in Arthritis and Rheumatism, Vol. 61

  11. Searching for a prognostic index in lupus nephritis

    European journal of medical research, Vol. 28, Núm. 1, pp. 19

  12. mTOR inhibitors in a patient with lupus nephritis; why not?

    Nefrologia

  13. mTOR inhibitors in a patient with lupus nephritis; why not?

    Nefrologia

2022

  1. Analysis of the factors predicting clinical response to tocilizumab therapy in patients with severe COVID-19

    International Journal of Infectious Diseases, Vol. 117, pp. 56-64

  2. Antimalarials exert a cardioprotective effect in lupus patients: Insights from the Spanish Society of Rheumatology Lupus Register (RELESSER) analysis of factors associated with heart failure

    Seminars in Arthritis and Rheumatism, Vol. 52